×
戻る Agenda
[Session 2] Non Clinical Proarrhythmic Risk Assessment
Session Chair(s)
Katsuyoshi Chiba, PHD
Senior Director and Head, Group III, Medicinal Safety Research Laboratories, R&D, Daiichi Sankyo Co., Ltd., Japan
Yasunari Kanda, PHD
Head of Division of Pharmacology, National Institute of Health Sciences, Japan
Speaker(s)
Keynote Lecture: Prediction and Quantification of Torsadogenic Potential Using Classical and New Assay Models
Professor and Chairman, Department of Pharmacology, Toho University Faculty of Medicine, Japan
CiPA: Validation Efforts and Update
Research Fellow, AbbVie Inc., United States
JiCSA Update: Proarrhythmia Risk Assessment Using Human iPS Cell-derived Cardiomyocytes
Head of Division of Pharmacology, National Institute of Health Sciences, Japan
iSmart (investigation of in silico / in vitro model for Arrhythmogenic Risk Prediction) Update
Senior Scientist, Pharmacokinetics and Safety Assessment Department, Nippon Shinyaku Co., Ltd., Japan